002688 金河生物
按盤價 
3.660 +0.030 (+0.826%)
3.660 +0.030 (+0.826%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.005 | 3.870 | 3.245 | 4.638 | 7.124 |
| 總資產報酬率 ROA (%) | 0.818 | 1.736 | 1.764 | 2.526 | 3.491 |
| 投入資產回報率 ROIC (%) | 0.948 | 2.008 | 2.021 | 2.844 | 3.895 | 邊際利潤分析 |
| 銷售毛利率 (%) | 34.184 | 29.552 | 28.916 | 31.332 | 34.715 |
| 營業利潤率 (%) | 9.623 | 4.817 | 5.712 | 6.723 | 7.133 |
| 息稅前利潤/營業總收入 (%) | 12.597 | 6.876 | 5.940 | 10.000 | 12.445 |
| 淨利潤/營業總收入 (%) | 9.159 | 4.344 | 5.564 | 5.875 | 7.671 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.353 | 114.388 | 116.439 | 100.918 | 89.389 |
| 價值變動淨收益/利潤總額(%) | -0.953 | -1.502 | -3.312 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 0.072 | -3.189 | -2.016 | 2.239 | 8.142 | 償債能力分析 |
| 流動比率 (X) | 1.016 | 0.904 | 1.049 | 1.418 | 0.903 |
| 速動比率 (X) | 0.675 | 0.606 | 0.643 | 0.922 | 0.577 |
| 資產負債率 (%) | 54.751 | 53.855 | 46.206 | 33.658 | 0.482 |
| 帶息債務/全部投入資本 (%) | 49.582 | 48.165 | 40.289 | 28.133 | 43.213 |
| 股東權益/帶息債務 (%) | 94.030 | 99.542 | 140.469 | 243.730 | 122.405 |
| 股東權益/負債合計 (%) | 73.751 | 76.496 | 106.646 | 178.228 | 99.260 |
| 利息保障倍數 (X) | 4.247 | 3.115 | 17.426 | 3.202 | 2.659 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 79.955 | 72.212 | 64.638 | 56.641 | 60.674 |
| 存貨周轉天數 (天) | 182.535 | 158.238 | 149.484 | 129.231 | 133.231 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/07/2024 10:36 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
